open access
Screening for atrial fibrillation: Different approaches targeted to reduce ischemic stroke


- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
open access
Abstract
Abstract


Title
Screening for atrial fibrillation: Different approaches targeted to reduce ischemic stroke
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Editorial
Pages
1-3
Published online
2022-12-05
Page views
84
Article views/downloads
37
DOI
10.33963/KP.a2022.0281
Pubmed
Bibliographic record
Kardiol Pol 2023;81(1):1-3.
Authors
Giuseppe Boriani
Jacopo F Imberti
Marco Vitolo


- Kalarus Z, Sredniawa B, Mitrega K, et al. Prevalence of atrial fibrillation in Polish population ≥65 old. Report of cross-sectional NOMED-AF study. Kardiol Pol. 2022 [epub ahead of print].
- Boriani G, Vitolo M, Lane DA, et al. Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology. Eur J Intern Med. 2021; 86: 1–11.
- Imberti JF, Mei DA, Vitolo M, et al. Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med. 2022; 101: 1–7.
- Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022; 24(6): 979–1005.
- Boriani G, Palmisano P, Malavasi VL, et al. Clinical factors associated with atrial fibrillation detection on single-time point screening using a hand-held single-lead ECG device. J Clin Med. 2021; 10(4).
- Boriani G, Vitolo M, Diemberger I, et al. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res. 2021; 117(7): 1–21.
- Boriani G, Maisano A, Bonini N, et al. Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey. J Geriatr Cardiol. 2021; 18(9): 739–747.
- Boriani G, Svennberg E, Guerra F, et al. Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey. Europace. 2022; 24(11): 1834–1843.
- Yousufuddin M, Jahangir A, Svennberg E, et al. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021; 398(10310): 1498–1506.
- Cichoń M, Mizia-Szubryt M, Olszanecka-Glinianowicz M, et al. Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion. Kardiol Pol. 2021; 79(3): 269–276.
- Boriani G, Valenti AC, Vitolo M. Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness. Kardiol Pol. 2021; 79(3): 243–245.
- Sgreccia D, Manicardi M, Malavasi VL, et al. Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients. J Clin Med. 2021; 10(17).
- Sun W, Freedman B, Martinez C, et al. Atrial fibrillation detected by single time-point handheld electrocardiogram screening and the risk of ischemic stroke. Thromb Haemost. 2022; 122(2): 286–294.
- Kahwati LC, Asher GN, Kadro ZO, et al. Screening for atrial fibrillation: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022; 327(4): 368–383.
- Brandes A, Stavrakis S, Freedman B, et al. Consumer-Led screening for atrial fibrillation: Frontier review of the AF-SCREEN International Collaboration. Circulation. 2022; 146(19): 1461–1474.